Study of the Long-term Safety of ALKS8700 in Adults with Relapsing Remitting Multiple Sclerosis

What we are studying

The purpose of this research study is to test the long-term safety and treatment effect of ALKS 8700 in subjects who have relapsing-remitting Multiple Sclerosis.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18 - 65

Eligibility Criteria

  • Relapsing-Remitting multiple sclerosis
  • 1 relapse within the previous year or two within the previous 2 years

What is involved

  • Physical Exams
  • Vital Signs
  • ECG
  • MRI
  • Neurological Exams
  • Questionnaires

Compensation

The subjects will be paid $960 in the form of a check if all the scheduled study visits are completed. If the subject withdraws for any reason from the study before completion then he/she will receive $60 for each complete study visit.

Contact Information

Study Coordinator
Janet Hutchens
Email
jahutche@wakehealth.edu
Phone
336-716-1715
Principal Investigator
Emily Pharr, MD

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.